₹ 0.1 Cr
Volume Transacted
(Nov 22, 2024)
1.0 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
ERIS Lifesciences Ltd
BSE
22 Nov, 2024
1376.1510.2 (0.7%)
Prev Close
1365.95
Open Price
1365.95
Bid Price (QTY)
Offer Price (QTY)
Volume
954
Today's High / Low
1393.9 / 1362.7
52 WK High / Low
1521.1 / 810.1
NSE
22 Nov, 2024
1374.27.3 (0.5%)
Prev Close
1366.9
Open Price
1376.95
Bid Price (QTY)
Offer Price (QTY)
Volume
27686
Today's High / Low
1395.5 / 1361.7
52 WK High / Low
1522.1 / 809.2
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 1376.15 | 1365.95 | 1393.9 | 1362.7 |
21 Nov 2024 | 1365.95 | 1391.7 | 1391.7 | 1350 |
19 Nov 2024 | 1364.4 | 1345 | 1428 | 1345 |
18 Nov 2024 | 1356.25 | 1340.85 | 1364.95 | 1324.85 |
14 Nov 2024 | 1353.8 | 1325.6 | 1367.05 | 1317.3 |
13 Nov 2024 | 1328.8 | 1390 | 1390 | 1312.95 |
12 Nov 2024 | 1367.75 | 1300.15 | 1396.35 | 1300.15 |
11 Nov 2024 | 1324.7 | 1303.45 | 1327.85 | 1298.6 |
08 Nov 2024 | 1303.45 | 1305 | 1308.3 | 1288.75 |
07 Nov 2024 | 1302.1 | 1299.6 | 1310.95 | 1290 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 1376.15 |
21 Nov 2024 | 1365.95 |
19 Nov 2024 | 1364.4 |
18 Nov 2024 | 1356.25 |
14 Nov 2024 | 1353.8 |
13 Nov 2024 | 1328.8 |
12 Nov 2024 | 1367.75 |
11 Nov 2024 | 1324.7 |
08 Nov 2024 | 1303.45 |
07 Nov 2024 | 1302.1 |
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Entity | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
---|
Cipla Ltd | 1.4 | -1.6 | -6.3 | 0.3 | 16.9 | 66.1 | 210.6 | 140.5 |
Torrent Pharmaceuticals Ltd | 2.1 | -5.0 | -5.7 | 18.9 | 50.0 | 130.2 | 270.4 | 527.5 |
Sun Pharmaceuticals Industries Ltd | 2.9 | -4.7 | 2.7 | 16.7 | 49.3 | 133.3 | 297.7 | 114.8 |
Divis Laboratories Ltd | 4.1 | 3.1 | 22.2 | 47.7 | 62.1 | 28.2 | 246.0 | 596.5 |
Mankind Pharma Ltd | -1.9 | -0.6 | 9.9 | 21.1 | 31.9 | 0.0 | 0.0 | 0.0 |
ERIS Lifesciences Ltd | 1.5 | 7.8 | 11.1 | 51.5 | 45.3 | 85.0 | 232.2 | 129.0 |
Entity | 1W |
---|---|
Cipla Ltd | 1.4 |
Torrent Pharmaceuticals Ltd | 2.1 |
Sun Pharmaceuticals Industries Ltd | 2.9 |
Divis Laboratories Ltd | 4.1 |
Mankind Pharma Ltd | -1.9 |
ERIS Lifesciences Ltd | 1.5 |
Last updated time: 23 Nov 14:40 PM
Parameter | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|
Sales | 750 | 856 | 982 | 1074 | 1212 | 1347 | 1733 | 2056 |
Sales YoY Gr. | - | 14.2% | 14.8% | 9.4% | 12.8% | 11.1% | 28.6% | 18.7% |
Adj EPS | 17.94 | 21.45 | 21.17 | 21.84 | 26.16 | 29.85 | 27.51 | 29.19 |
YoY Gr. | - | 19.6% | -1.3% | 3.2% | 19.8% | 14.1% | -7.8% | 6.1% |
Adj Net Profit | 247 | 295 | 291 | 297 | 355 | 406 | 374 | 397 |
BVPS | 41.25 | 62.64 | 83.66 | 95.47 | 116.1 | 140.36 | 161.48 | 190.11 |
Parameter | 2017 |
---|---|
Sales | 750 |
Sales YoY Gr. | - |
Adj EPS | 17.94 |
YoY Gr. | - |
Adj Net Profit | 247 |
BVPS | 41.25 |
Parameter | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|
Return on Capital Emp. % | 45.31 | 50.46 | 59.16 | 34.85 | 26.04 | 24.8 | 26.81 | 24.45 | 16.68 | 12.05 |
Op. Profit Mgn % | 22.53 | 28.48 | 39.26 | 40.73 | 38.36 | 35.74 | 36.26 | 37.94 | 31.62 | 33.98 |
Net Profit Mgn % | 16.1 | 21.94 | 32.9 | 34.48 | 29.64 | 27.61 | 29.31 | 30.12 | 21.59 | 19.31 |
Debt to Equity % | 0 | 0 | 0 | 0.26 | 0.27 | 0.07 | 0 | 0.03 | 0.23 | 0.76 |
Parameter | 2015 |
---|---|
Return on Capital Emp. % | 45.31 |
Op. Profit Mgn % | 22.53 |
Net Profit Mgn % | 16.1 |
Debt to Equity % | 0 |
No data available
No data available
Unlimited trading at just
Rs. 199*